药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zinc
Tixocortol
The risk or severity of adverse effects can be increased when Tixocortol is combined with Hydrocortisone acetate.
Zinc
Fluprednidene
The risk or severity of adverse effects can be increased when Fluprednidene is combined with Hydrocortisone acetate.
Zinc
Bleselumab
The risk or severity of adverse effects can be increased when Hydrocortisone acetate is combined with Bleselumab.
Zinc
Rozanolixizumab
The risk or severity of adverse effects can be increased when Hydrocortisone acetate is combined with Rozanolixizumab.
Zinc
Risankizumab
The risk or severity of adverse effects can be increased when Hydrocortisone acetate is combined with Risankizumab.
Zinc
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Monomethyl fumarate is combined with Hydrocortisone acetate.
Zinc
Begelomab
The risk or severity of adverse effects can be increased when Begelomab is combined with Hydrocortisone acetate.
Zinc
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when 9-(N-methyl-L-isoleucine)-cyclosporin A is combined with Hydrocortisone acetate.
Zinc
Hypericin
The risk or severity of adverse effects can be increased when Hypericin is combined with Hydrocortisone acetate.
Zinc
Acteoside
The risk or severity of adverse effects can be increased when Acteoside is combined with Hydrocortisone acetate.
Zinc
Deoxyspergualin
The risk or severity of adverse effects can be increased when Deoxyspergualin is combined with Hydrocortisone acetate.
Zinc
Doxifluridine
The risk or severity of adverse effects can be increased when Doxifluridine is combined with Hydrocortisone acetate.
Zinc
Trofosfamide
The risk or severity of adverse effects can be increased when Trofosfamide is combined with Hydrocortisone acetate.
Zinc
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Cepeginterferon alfa-2B is combined with Hydrocortisone acetate.
Zinc
Gusperimus
The risk or severity of adverse effects can be increased when Gusperimus is combined with Hydrocortisone acetate.
Zinc
Mizoribine
The risk or severity of adverse effects can be increased when Mizoribine is combined with Hydrocortisone acetate.
Zinc
Ocrelizumab
The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Hydrocortisone acetate.
Zinc
Guselkumab
The risk or severity of adverse effects can be increased when Guselkumab is combined with Hydrocortisone acetate.
Zinc
Sirukumab
The risk or severity of adverse effects can be increased when Sirukumab is combined with Hydrocortisone acetate.
Zinc
Brodalumab
The risk or severity of adverse effects can be increased when Brodalumab is combined with Hydrocortisone acetate.